ArticleMolecular cancer therapeutics2021

PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition-Dependent GSK-3β-Mediated c-Myc and Pim-1 Proteasomal Degradation.

Mario Scarpa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.